How are NKTR collar max profit and max loss calculated?

Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the NKTR collar priced from the September 30, 2026 end-of-day chain at a 30-day expiry (ATM IV 81.90%), the computed maximum profit is $310.00 per contract and the computed maximum loss is -$190.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a NKTR collar?

The breakeven for the NKTR collar priced on this page is roughly $61.90 at expiration, derived from the September 30, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The NKTR market-implied 1-standard-deviation expected move in the same options snapshot is approximately 23.48%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current NKTR implied volatility affect this collar?

NKTR ATM IV is at 81.90% with IV rank near 22.00%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

NKTR Collar Strategy

NKTR (Nektar Therapeutics), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Nektar Therapeutics is a biopharmaceutical firm dedicated to the global discovery and advancement of therapies addressing significant unmet medical requirements. Central to its robust pipeline is Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist. This drug is currently in Phase 3 clinical trials for metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, head and neck squamous cell carcinoma, and adjuvant melanoma. It is also being evaluated in Phase 2 for renal cell carcinoma, non-small cell lung cancer, and urothelial cancer; Phase 1/2A for head and neck squamous cell carcinoma; Phase 1/2 for various solid tumors; and Phase 1B for COVID-19. Additionally, Nektar is developing NKTR-358, a cytokine Treg stimulant, which is in Phase 2 trials for systemic lupus erythematosus and ulcerative colitis, and Phase 1B for atopic dermatitis and psoriasis. Their portfolio further includes NKTR-255, an IL-15 receptor agonist, undergoing Phase 1/2 trials for non-Hodgkin's lymphoma, multiple myeloma, head and neck cancer, and colorectal cancer.

NKTR (Nektar Therapeutics) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.74B, a beta of 1.15 versus the broader market, a 52-week range of 33.4-109, average daily share volume of 1000K, a public-listing history dating back to 1994, approximately 63 full-time employees. These structural characteristics shape how NKTR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.15 places NKTR roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a collar on NKTR?

A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.

NKTR snapshot

As of September 30, 2026, spot at $60.95, ATM IV 81.90%, IV rank 22.00%, expected move 23.48%. The collar on NKTR below is built from the September 30, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 51-day expiry.

Why this collar structure on NKTR specifically: IV regime affects collar pricing on both sides; compressed NKTR IV at 81.90% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 23.48% (roughly $14.31 on the underlying). The 51-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated NKTR expiries trade a higher absolute premium for lower per-day decay. Position sizing on NKTR should anchor to the underlying notional of $60.95 per share and to the trader's directional view on NKTR stock.

NKTR collar setup

The NKTR collar below is built from the September 30, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With NKTR at $60.95 on that close, the first option leg uses a $65.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed NKTR chain at a 51-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 NKTR shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 100 shares	Stock	$60.95	long
Sell 1	Call	$65.00	$5.05
Buy 1	Put	$60.00	$6.00

NKTR collar risk and reward

Net Premium / Debit: -$6,190.00
Max Profit (per contract): $310.00
Max Loss (per contract): -$190.00
Breakeven(s): $61.90
Risk / Reward Ratio: 1.632

Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.

NKTR collar payoff curve

Modeled P&L at expiration across a range of underlying prices for the collar on NKTR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	-$190.00
$13.49	-77.9%	-$190.00
$26.96	-55.8%	-$190.00
$40.44	-33.7%	-$190.00
$53.91	-11.5%	-$190.00
$67.39	+10.6%	+$310.00
$80.86	+32.7%	+$310.00
$94.34	+54.8%	+$310.00
$107.81	+76.9%	+$310.00
$121.29	+99.0%	+$310.00

When traders use collar on NKTR

Collars on NKTR hedge an existing long NKTR stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.

NKTR thesis for this collar

The market-implied 1-standard-deviation range for NKTR extends from approximately $46.64 on the downside to $75.26 on the upside. A NKTR collar hedges an existing long NKTR position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current NKTR IV rank near 22.00% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on NKTR at 81.90%. As a Healthcare name, NKTR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to NKTR-specific events.

NKTR collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. NKTR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move NKTR alongside the broader basket even when NKTR-specific fundamentals are unchanged. Always rebuild the position from current NKTR chain quotes before placing a trade.

Frequently asked questions

What is a collar on NKTR?: A collar on NKTR is the collar strategy applied to NKTR (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With NKTR stock at $60.95 on the September 30, 2026 close, the strikes shown on this page are snapped to the nearest listed NKTR chain strike and the premiums come straight from that session's bid/ask midpoint.
How are NKTR collar max profit and max loss calculated?: Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the NKTR collar priced from the September 30, 2026 end-of-day chain at a 30-day expiry (ATM IV 81.90%), the computed maximum profit is $310.00 per contract and the computed maximum loss is -$190.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a NKTR collar?: The breakeven for the NKTR collar priced on this page is roughly $61.90 at expiration, derived from the September 30, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The NKTR market-implied 1-standard-deviation expected move in the same options snapshot is approximately 23.48%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a collar on NKTR?: Collars on NKTR hedge an existing long NKTR stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
How does current NKTR implied volatility affect this collar?: NKTR ATM IV is at 81.90% with IV rank near 22.00%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.